Human embryos often fail to cope with high levels of replication stress early in development. Their failure not only impairs fertility treatment but may have long-ranging impacts on our health.
Understanding what drives gut stem cells to work nonstop may reveal how idle stem cells elsewhere can be revved up to repair hearts, lungs, and brains. But are scientists studying the right cells?
A 24-hour fast followed by feeding rejuvenates the blood-forming stem cells in old mice, a finding that may lead to new ways to help people live healthier lives as they age.
A new study reveals how bone marrow stem cell niche generation is regulated, which could lead to improvements in stem cell transplantation for the treatment of blood diseases.
Columbia University Medical Center researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa, a leading cause of vision loss.
Scientists at the New York Stem Cell Foundation and CUMC have created the first disease-specific embryonic stem cell line using nuclear transfer technology.
Using stem cells from patients, P&S researchers have created a model of age-related macular degeneration in a dish, which may lead personalized treatments to prevent vision loss.
Stem cells created from the skin of patients with a rare form of diabetes have been used to elucidate an important biochemical pathway for beta-cell failure in diabetes.
Study of insulin-producing cells derived from skin of diabetes patients shows utility of iPS cells for study of human disease and as potential therapy.